Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001449123 | SCV001652228 | likely benign | Amyloidosis, hereditary systemic 1 | 2022-11-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001539583 | SCV001757371 | benign | not provided | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002476766 | SCV002802555 | likely benign | Hyperthyroxinemia, dystransthyretinemic; Amyloidosis, hereditary systemic 1; Carpal tunnel syndrome 1 | 2022-04-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004681183 | SCV005180177 | likely benign | Cardiovascular phenotype | 2024-03-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |